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Abstract
Background Among the modalities for lung imaging, pro-
ton magnetic resonance imaging (MRI) has been the latest to
be introduced into clinical practice. Its value to replace X-
ray and computed tomography (CT) when radiation expo-
sure or iodinated contrast material is contra-indicated is well
acknowledged: i.e. for paediatric patients and pregnant
women or for scientific use. One of the reasons why MRI
of the lung is still rarely used, except in a few centres, is the
lack of consistent protocols customised to clinical needs.
Methods This article makes non-vendor-specific protocol
suggestions for general use with state-of-the-art MRI scan-
ners, based on the available literature and a consensus dis-
cussion within a panel of experts experienced in lung MRI.
Results Various sequences have been successfully tested
within scientific or clinical environments. MRI of the lung
with appropriate combinations of these sequences comprises
morphological and functional imaging aspects in a single
examination. It serves in difficult clinical problems encoun-
tered in daily routine, such as assessment of the mediasti-
num and chest wall, and even might challenge molecular
imaging techniques in the near future.
Conclusion This article helps new users to implement ap-
propriate protocols on their own MRI platforms.
Main Messages
• MRI of the lung can be readily performed on state-of-the-
art 1.5-T MRI scanners.
• Protocol suggestions based on the available literature
facilitate its use for routine
• MRI offers solutions for complicated thoracic masses with
atelectasis and chest wall invasion.
• MRI is an option for paediatrics and science when CT is
contra-indicated
Keywords Magnetic resonance imaging . Lung, sequence .
Imaging protocol
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Introduction
Increasingly, magnetic resonance imaging (MRI) of the
lung is being advanced from a technological niche to the
doorsteps of clinical routine imaging. The key technique
for MRI of lung morphology is based on the resonant
high-frequency signal of protons in tissues and liquids,
so-called proton-MRI or 1H-MRI. The recent technical
advances have helped MRI to challenge its well-known
limitations as they are defined by the low proton density
in the lung and the fast signal decay due to susceptibility
artefacts at air-tissue interfaces [1]. Besides chest radiog-
raphy, the most commonly employed first-line test for
chest disorders, and computed tomography (CT), so far
the most comprehensive and detailed modality for cross-
sectional and three-dimensional (3D) imaging of the lung,
MRI is becoming an alternative, third method for the
assessment of pulmonary diseases. Once broadly avail-
able and sufficiently robust, it will likely become a
modality of choice for cases in which exposure to ionis-
ing radiation should be strictly avoided. This would
comprise children, pregnant women and disorders requir-
ing repeated examinations over prolonged periods, such
as in patients with neutropenia, in which MRI could
contribute significantly to lowering the cumulative radia-
tion dose [2].
However, MRI offers additional advantages beyond the
scope of X-ray-based techniques due to its functional imag-
ing capacities. More than any other modality, MRI com-
bines excellent soft tissue contrast and functional
information [3]. It allows for multiple and repeated measure-
ments and can be used to assess motion and perfusion of the
thoracic organs. These advantages are already well appreci-
ated in MRI of the heart, which combines morphological
information (wall thickness, edema, scarring of the myocar-
dium) with functional assessment (wall motion, contractili-
ty, ejection fraction) and viability/perfusion (e.g. at rest and
during stress) [4]. Advances in MRI technology and a broad
consensus on the basic imaging protocols have helped to
establish a complex technology such as cardiac MRI within
a relatively short period of time.
Since imaging technology has brought similar advances to
MRI of the lung, it is basically the lack of comprehensive and
standardised imaging protocols that delay its introduction for
broader clinical use [5]. A number of applicable sequence
techniques have been introduced and tested to various
degrees. Every single sequence covers different aspects of
lung pathology, e.g. liquid content of infiltrates or sharp
delineation of solid nodules, etc. Sequence packages and
customised protocols to combine strengths and diagnostic
yields of the available sequences have been suggested (for
an example of detailed vendor-specific recommendations see:
Biederer J, Hintze C, Fabel M, Jakob PM, Horger W,
Graessner J, Bolster BD, Heller M (2011) MRI of the lung—
ready… get set… go! Magnetom Flash 46:6-15; http://www.
medical.siemens.com/siemens/en_GLOBAL/rg_marcom_F
BAs/files/apps/magazine/magnetom_flash/2011-05/Fla
sh_46_einzel_final.pdf). However, based on the platforms of-
fered by different vendors, the protocols tend to be difficult to
compare and make clinical introduction unnecessarily compli-
cated. On the occasion of the first European School of Radi-
ology courses on lung MRI and dedicated sessions at the
European Congress of Radiology (ECR) 2010 and the
European Society of Thoracic Imaging (ESTI) meeting
2010 as well as the meeting of the Chest Imaging Work-
shop (AG Thorax) at the German Roentgen Society
(DRG), it was suggested that a group of experts in the
field should generate a consensus statement on the current
state of the art, indications and applications and future
developments of lung MRI. After introducing the principles
of the available technology in the first of this set of three
articles [MRI of the lung (1/3)], it is the aim of the
following lines to summarise the currently available proto-
cols, comment on their clinical value based on the discus-
sions within a panel of experts who are already practising
lung MRI and to make updated uniform protocol sugges-
tions for general use at state-of–the-art MRI scanners. A third
manuscript will subsequently describe the current applications
and future directions of lung MRI [MRI of the lung (3/3)].
Expectancies to be met by MRI of the lung
The prerequisites for the introduction of a new technique into
the clinical setting are practicality of the application as well as
robustness and reproducibility of image quality and diagnostic
accuracy. The practicality of an MRI technique is further
enhanced by a set of readily prepared protocols customised
for specific clinical questions and available for standard scan-
ners [1.5 Tesla (T)]. Preferably, additional features complicat-
ing the procedure such as the need for ECG-triggering or
contrast material administration would be avoided. Further-
more, solutions for typical problems such as patients not being
able to hold their breath or young children should be offered. In
practice, it has been useful to design a common basic protocol
trunk to cover the majority of expected clinical problems [1].
This basic protocol will be extended for specific questions such
as the staging of malignancy, evaluation of pulmonary vessels
and perfusion, etc. Furthermore, if the use of MRI is intended
for emergency conditions, such as acute pulmonary embolism,
fast and efficient procedures are required with in-room times
that make it possible to squeeze the exam into a full MR
schedule during the day [5]. Given the high investment into
state-of-the-art MRI equipment and the running costs for
maintenance and personnel, the key parameter for cost-
effectiveness of the method is in-room time. Based on the
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currently available standards, in-room times of 15 min for the
basic protocol or an emergency examination were considered
desirable [1]. Additional protocol extensions, e.g. contrast-
enhanced series, to detect tumour necrosis and pleural reac-
tion/carcinosis or dynamic contrast-enhanced MRI and visual-
isation of respiratory motion contribute functional information
should not exceed further 5-15 min in addition to the time
needed for the basic protocol. To match this frame of expec-
tancies as far as possible was the aim of the presented consen-
sus on lungMRI protocol suggestions. Tables 1, 2, 3, 4 provide
a systematic overview over indications for lung MRI and
imaging protocol set-ups as well as a list of abbreviations/
glossary of terms in order to facilitate comparisons and cross-
vendor correlation throughout the manuscript.
Experience with MRI for the evaluation of pathological
conditions in the lung
Pathological conditions in the lung related to changes of
lung structure result either in an increase of lung density
(collapse of lung with atelectasis, fluid accumulation inside
the alveolar space and/or the lung interstitium, fluid and cell
accumulation in infiltrates or growth of soft tissue resulting
in nodules and masses) or decrease of lung density (over-
inflation due to air-trapping, enlargement of air spaces in
emphysema) [6–10]. Given the well-known limitations of
MRI in visualising low-proton-density structures with high
susceptibility artefacts at tissue-air interfaces, any pathology
resulting in an increase of lung density (and consequently
Table 1 Indications for lung MRI (in compliant patients)
Role of MRI Situation/pathological condition i.v. contrast
Situations that warrant the use of MRI Children Optional
Pregnant women Optional
Young patients with need for repeated imaging of the lungs Optional
To replace CT if contrast media are contra-indicated Optional
Scientific studies Optional
Pharmaceutical trials Optional
In discussion: lung cancer screening Optional
Indications covered by MRI Complicated thoracic mass (mediastinum and chest wall invasion)a Optional
with advantages over CT Differentiation of atelectasis and pulmonary massa Optional
Differentiation of mediastinal masses Optional
Evaluation of respiratory mechanics No
Diagnosis of pulmonary perfusion deficits (embolism, hypoxic vasoconstriction) Yes
Cystic fibrosis (with perfusion study)a Yes
Indications covered by MRI Pneumonia No
as effectively as with CT Atelectasis No
(if situation warrants use of MRI) Cystic fibrosis (without perfusion study)a No
Tuberculosis No
Pulmonary nodules (> 3 mm) No
Sarcoidosis Optional
Acute and chronic pulmonary embolisma Yes
Abnormalities of pulmonary venous drainage Yes
Pulmonary arterial aneurysm Yes
Lung sequestration Yes
AV malformation (M. Osler) Yes
Staging of lung cancer Yes
Vasculitis (e.g. Wegener’s) Yes
Pleural effusion of unclear origin Yes
Mesothelioma Yes
Indications covered less effectively Pulmonary miconodules (< 3 mm) Optional
than with CT Interstitial lung diseasea Optional
Emphysema/COPD* Optional
a Specific topics covered with more detail in the third article of this series
Insights Imaging (2012) 3:355–371 357
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Table 4 List of abbre-
viations/acronyms as
used in the text and in
Tables 2 and 3
½ NEX Half Fourier acquisition (GE)
2D Two-dimensional (single image in one plane)
2D+t Temporally resolved (dynamic) imaging in a single plane (used to differentiate from 3D for spatially
resolved acqisitions)
3D Three-dimensional (spatial resolution)
3D+t Temporally resolved (dynamic) imaging in multiple volumes
4D Four-dimensional (with spatial and temporal resolution, a term often used as synonym to 3D+t)
AFI RO Advanced Fourier imaging in read out (partial/half Fourier acquisition sequence; Toshiba)
ASL Arterial spin labeling
BASG Balanced spoiled steady state acquisition rewinded gradient (gradient echo sequence with steady
state acquisition; Hitachi)
bFFE Balanced fast field echo (gradient echo sequence with steady state acquisition; Philips)
BLADE Brand name/not an acronym (rotating phase encoding sequence; Siemens)
Body Vision Brand name/not an acronym (diffusion weighted imaging sequence; Toshiba)
ce Contrast enhanced
CT Computed tomography
DCE MRI Dynamic contrast enhanced MRI (can be 2D+t or 3D+t)
DRKS Different rate k-space sampling (temporally resolved 3D gradient echo sequence with temporal
resolution (3D+t) achieved by echo sharing; Toshiba)
DWI diffusion-weighted imaging
DWIBS Diffusion-Weighted whole body Imaging with body BBackground signal Suppression (diffusion-
weighted imaging sequence; Philips)
FE Field echo (gradient echo sequence syn. to flash; Toshiba, Philips)
FFE Fast field echo (gradient echo sequence syn. to flash; Toshiba, Philips)
FIESTA Fast imaging employing steady state acquisition (gradient echo sequence with steady state
acquisition; GE)
Flash Fast low angle shot (the basic technique for GE sequences; Siemens)
FSE Fast spin echo (sequence; GE, Hitachi, Toshiba)
GE Gradient echo (gradient echo sequence)
GRE Gradient recalled echo (gradient echo sequence)
Half scan Half Fourier acquisition technique (Philips, Hitachi)
HASTE Half Fourier short turbo spin echo (sequence; Siemens)
JET Brand name/not an acronym (rotating phase encoding sequence; Toshiba)
LAVA Liver acquisition with volume acceleration (a 3D gradient echo sequence with volume interpolation
and RF fat saturation; GE)
MRA Magnetic resonance angiography
MRI Magnetic resonance imaging (MR imaging)
MultiVane Brand name/not an acronym (rotating phase encoding sequence; Philips)
PROPELLER Periodically Rotated Overlapping Parallel Lines with Enhanced Reconstruction (rotating phase
encoding sequence; GE)
Quick3D 3D gradient echo with volume interpolation (sequence; Toshiba)
RADAR Radial acquisition regime (rotating phase encoding sequence; Hitachi)
REVEAL Brand name/not an acronym (diffusion weighted imaging sequence; Siemens)
RF Radio frequency
SARGE Spoiled steady state acquisition rewinded gradient echo (sequence syn. to flash; Hitachi)
SF6 Sulphur hexafluoride
SPGR Spoiled gradient echo recalled (sequence syn. to flash; GE)
SSFP Steady state free precession (gradient echo sequence with steady state acquisition)
STIR Short tau inversion recovery (sequence)
T Tesla (unit for field strength)
T1, T2 Time constants for signal decay in MRI
T1-w./T2-w. Sequences producing images with T1- or T2-weighted contrast
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proton density) should be easy to detect, while a decrease of
lung density will remain more challenging to visualise with
MRI [8]. However, most conditions resulting in destruction
and over-inflation of lung parenchyma, such as in emphyse-
ma, are associated with characteristic changes in the remain-
ing lung parenchyma (fibrosis, septae, parenchymal
distortion, bronchial wall thickening, etc.). Hence morpholog-
ical MRI can still provide a correct diagnosis based on wid-
ened spaces of missing signal due to over-inflation and
associated findings with increased signal intensity [11]. A
direct visualisation of the airspace remains the domain of
sophisticated imaging technology in specialised centres (see
airways and lung ventilation disorders). Furthermore, changes
in lung perfusion (hypoxic vasoconstriction, pulmonary em-
bolism, congestion due to heart failure) result in changes of
lung signal on MRI [7]. Non-enhanced MRI can directly
visualise the vessel tree to detect macro-vascular pathology.
Pathological conditions with increased signal intensity
Quite a lot of experience exists for detection of pathological
conditions that result in an increase of lung proton density.
Experimental work has shown the high sensitivity of MRI
with T2-weighted and proton-density weighted sequences
for fluid accumulation inside the lung [12–14]. One can
conclude that the sensitivity of MRI for pulmonary infil-
trates is at least as good as with chest radiography and CT
[2, 12, 15–17]. The majority of the applied protocols are
based on T2-weighted or proton-density-weighted fast spin
echo sequences, either with respiration gating or triggering
or in breath-hold acquisition modes (Fig. 1).
Another key clinical demand is the detection of small
solid or soft tissue lesions (“nodules”). The sensitivity of
MRI for lung nodules larger than 4 mm ranges between 80
and 90% and reaches 100% for lesions larger than 8 mm
[18]. Depending on the sequence technique and the signal
intensity of the lesions and given that conditions are optimal
(i.e. patient can keep a breath-hold for 20 s or perfect gating/
triggering), a threshold size of 3-4 mm can be assumed for
lung nodule detection with MRI [19, 20]. In comparison
with CT, it might be even faster and more efficient to read
lung MRI for pulmonary nodules, since they appear with
bright signal against the dark background of the healthy
lung tissue [21] (Fig. 2). Calcified nodules tend to disappear
in the background, as they have no inherent signal, whereas
contrast-filled vascular lesions will be highly visible on T1-
weighted images [22]. So far, a variety of sequence types
has been evaluated for lung nodule detection with MRI. The
spectrum comprises T2-weighted fast spin echo imaging
with and without fat saturation [23–26], inversion recovery
techniques [27], T1-spin echo [26, 28] and gradient echo
sequences [29, 30].
The implications for protocol design are to include at
least one T2-weighted or proton-density-weighted or short
tau inversion recovery (STIR) sequence to cover infiltrates
and nodular lesions with high fluid content. This should be
combined with a second sequence to cover nodules with
high signal on T1-weighted images as well. In particular, for
the detection of malignant lesions with hyperperfusion and
intense enhancement, the i.v. administration of paramagnet-
ic contrast material might be helpful and even increase
detection rates. However, this has not yet been confirmed
by appropriate studies so far.
Not yet clarified is the role of diffusion-weighted imaging
(DWI) of lung lesions. DWI is recommended for the whole-
body staging of lung cancer, including mediastinal
Table 4 (continued)
½ NEX Half Fourier acquisition (GE)
THRIVE T1 high resolution isotropic volume excitation (a 3D gradient echo sequence with volume
interpolation and RF fat saturation; Philips)
TIGRE Brand name/not an acronym (a 3D gradient echo sequence with volume interpolation and RF fat
saturation; Hitachi)
TRAK Time-resolved angiography using keyhole (a temporally resolved 3D gradient echo sequence with
temporal resolution (3D+t) achieved by echo sharing; Philips)
TRICKS Time-resolved imaging of contrast kinetics (a temporally resolved 3D gradient echo sequence with
temporal resolution (3D+t) achieved by echo sharing; GE)
TrueFISP True fast imaging with steady state precession (gradient echo sequence with steady state acquisition;
Siemens)
TrueSSFP True steady state free precession (gradient echo sequence with steady state acquisition; Toshiba)
TSE Turbo spin echo (fast spin echo sequence; Siemens, Philips)
TWIST Time-resolved angiography with stochastic trajectories (temporally resolved 3D gradient echo
sequence with temporal resolution (3D+t) achieved by echo sharing; Siemens)
VIBE Volumetric interpolated breath hold examination (a 3D gradient echo sequence with volume
interpolation and RF fat saturation; Siemens)
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metastases [31, 32]; however, in the chest a clear advantage
of DWI over other MRI protocols has not been confirmed so
far [33, 34]. STIR sequences might be even more sensitive
for the detection and classification of lung cancer and me-
diastinal metastases than DWI [35–37]. One potential role
of DWI might be to predict tumour invasiveness for clinical
stage IA non-small-cell lung cancer and to separate the mass
from atelectasis [38, 39]. The role of DWI sequences for the
differentiation of malignant or benign lung lesions or for the
discrimination of subtypes of lung cancer remains contro-
versial [37, 40–42]. In the authors’ own experience, DWI
helps to demarcate lesions adjacent to the pleura (Fig. 3),
assess mediastinal extension and may serve as a “second
reader” for detection of small nodules. Thus, it makes sense
Fig. 1 A 66-year-old male pa-
tient with fever and coughing,
clinically suspected pneumonia.
The plain chest X-ray (a) dem-
onstrates a dense infiltrate in the
left lower lung lobe which is
confirmed on non-contrast-
enhanced low dose CT (b;
arrows). The patient volun-
teered to undergo MRI on the
same day. Multi-breath-hold
coronal T2-weighted fast spin
echo (c) and single breath-hold
T1-weighted 3D GRE imaging
(d) as well as free breathing
coronal steady state SSFP
(e) and multi-breath-hold
fat-saturated T2-weighted fast
spin echo series (f) clearly
demonstrate the infiltrates
with particularly high signal
on T2-weighted images
Fig. 2 A 64-year-old woman
with the incidental finding of an
unspecific, 4-mm nodule in the
right middle lobe. The nodule
(open arrow) is clearly depicted
on the coronal multi-breath-hold
T2-weighted (a) and transverse
contrast-enhanced, fat-saturated
3D GRE images (b)
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to include a fast DWI acquisition in the protocol recommen-
dations for MRI of the lung [43, 44].
Vessels and lung perfusion disorders
Thus far, approaches for disorders of pulmonary perfusion
have been aimed at either the visualisation of the pulmonary
arterial tree (MR angiography) or at the assessment of lung
parenchyma signal changes associated with perfusion on
contrast-enhanced or non-contrast-enhanced scans.
MR angiography and MR perfusion have mainly been
applied for the study of acute pulmonary embolism, a key
clinical entity to demonstrate diagnostic accuracy. Many
approaches include direct visualisation of the thrombus inside
the pulmonary artery either with positive or negative contrast
against the signal of the flowing blood. Presently, fast steady
state free precession gradient echo sequences (SSFP-GRE)
appear to be one of the most effective techniques. They
display the lung vessels with bright signal, against which
thrombotic material is contrasted with low signal intensity. A
sensitivity of 90% and a specificity of 97% have been reported
for acute segmental pulmonary embolism [45–47]. Another
approach has used double inversion recovery, demonstrating
stagnant blood clot as bright signal, but insufficient data exist
as to the diagnostic accuracy at this time [48, 49].
The presently most powerful technique, however,
appears to be high spatial resolution MR angiography with
T1-weighted contrast-enhanced 3D gradient echo acquisi-
tions with k-space centred contrast bolus in a breath-hold
[50]. For optimum contrast, it is recommended to use a
power injector and selected injection protocols [51]. Several
studies have shown very encouraging results for MR angi-
ography (MRA) in the workup of patients with suspected
pulmonary embolism [52–55]. Most recently, the PIOPED
III study involving seven centres and 371 patients with
suspected pulmonary embolism demonstrated sufficient im-
age quality in only 75% of the patients. Sensitivity and
specificity for acute pulmonary embolism were 78% and
99%, respectively [56]. The most frequent reason for insuf-
ficient image quality was dyspnoea, coughing or insufficient
timing of contrast material injection. To overcome the
problem of bolus timing, other approaches favoured time-
resolved MRA with multiple acquisitions of lung volumes
using very fast 3D gradient echo techniques. Extremely
short acquisition times of 1.5 s or less were achieved by
combining parallel imaging and data sharing [57]. With a
so-called 4D MRA or dynamic first-pass perfusion MRI
[also known as dynamic contrast enhanced (DCE)-MRI],
Ersoy et al. [58] realised a sensitivity of 98% for lobar and
92% for segmental embolism.
The development of dynamic first pass perfusion MRI
has opened further perspectives in studying lung parenchy-
ma perfusion in other disease conditions than pulmonary
embolism as well. Limited to one plane, the temporally
resolved so-called two-dimensional dynamic (2D+t) perfu-
sion MRI reaches excellent temporal resolution of up to 10
images/s with reasonable spatial resolution [59]. However,
volume coverage needs multiple series and contrast injec-
tions, which are usually not feasible. Thus, 4D approaches
are usually preferred. Other techniques such as arterial spin
labeling (ASL) based on intrinsic contrast of magnetised,
inflowing blood into the imaging plane or volume have been
investigated and applied for scientific studies, but have not
yet found their way into clinical applications [60, 61].
The visual evaluation of 4D MRI image sets is facilitated
by subtraction of the non-enhanced from the contrast-
enhanced image signal, which results in a bright display of
the contrast-enhanced lung vessels and parenchyma. The
clinical value of lung perfusion studies with visual and
semi-quantitative evaluation is being tested in the assess-
ment of lung perfusion deficits in cystic fibrosis patients
who suffer from mucus retention and hypoxic vasoconstric-
tion (Fig. 4) [62–64]. The perfusion series allows indirect
visualisation of lung parenchyma abnormalities due to em-
physema or conditions such as pneumothorax due to the
absence of perfused lung tissue.
Airways and lung ventilation disorders
Direct visualisation of the airways with MRI is limited to
airways in excess of 3 mm diameter, unless filled with bright
materials such as retained mucus in cystic fibrosis patients
Fig. 3 Diffusion-weighted
imaging highlighting pleural
metastases of hepatocellular
carcinoma at the right
diaphragm (left, open arrow).
The same spots are only hardly
visible on the post-contrast fat-
saturated breath-hold T1-
weighted 3D GRE sequence
(right).
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[65, 66] (Fig. 5). In young healthy subjects, lung MRI
depicted airways down to the first subsegmental level; how-
ever, in parts of the lung subject to cardiac pulsation, detec-
tion rates were significantly lower [67]. As expected from
the higher spatial resolution, high resolution CT is still
superior to MRI in the depiction of small peripheral airways.
However, MRI is capable of studying dynamic processes,
e.g. to analyse respiratory motion of the lung, diaphragm
and relationships of tumours to chest wall boundaries. The
technical advances described above for 2D+t MRI or 3D+t
MRI with different variants of T1-weighted gradient echo or
steady state free precession sequences have been applied for
this purpose [68, 69]. One of the most important clinical
applications will be radiotherapy planning for organs with
respiration-correlated motion [70, 71]. Lung ventilation can
be estimated from regional volume changes [72].
Since air has no signal on MRI, ventilation can only be
visualised directly with hyperpolarised noble gases [73],
sulphur hexafluoride (SF6) [74] or tracked indirectly by
signal changes after inhalation of 100% oxygen [75] or
inhalation of aerosol of a paramagnetic contrast agent [76].
Despite the fascinating scientific publications obtained with
these approaches, most of them are still remote from clinical
application. Presently, the use of dynamic image acquisi-
tions in single 2D planes (2D+t) to study respiratory motion
appears to be closest to routine use.
Further aspects to be covered
Apart from the conditions mentioned above, the spectrum of
findings to be covered comprises a wide range of disorders,
ranging from pleural pathology (effusion, empyema, tumour
with chest wall infiltration, pneumothorax) to mediastinal
involvement (masses, lymphnodes, vascular pathologies)
and the assessment of the adjacent upper abdomen (e.g.
adrenal and liver metastases in lung cancer). It would be
beyond the scope of this article to discuss the role of MRI in
all of these conditions, since this is well covered by standard
textbooks. Nevertheless, any suggested standard protocol
for lung diseases should offer sufficient coverage of the
surrounding structures, which may then be further examined
with dedicated protocols. A wide field, for instance, is the
interaction between the heart and the lung. To keep within
Fig. 4 An 18-year-old male cystic fibrosis patient, coronal T2-
weighted half Fourier fast spin echo sequence (a) and coronal subtrac-
tion perfusion image (b). Notice the severe mucus plugging in the
morphological T2-weighted image. The subtraction perfusion image
shows correspoding areas with perfusion loss due to hypoxic vasocon-
striction. Due to redistribution of perfusion both lower lobes show a
high perfusion signal
Fig. 5 Lung MRI of a 37-year-old male patient with cystic fibrosis.
Coronal T2-weighted, respiration triggered and transverse breath-hold
T1-weighted 3D GRE images show peripheral airways with enhanced
signal due to mucus plugging. Note the “tree-in-bud” sign similar to
the typical appearance on CT (dashed circles)
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the frame of this article, the possible useful combinations of
lung MRI protocol components with heart MRI protocols
will not be discussed explicitly. However, their clinical
value is obvious and building flexibility into the protocol
trees is suggested, which would allow the user to combine
protocols as required.
Getting started (or what you may need to know to avoid
disappointments)
More than in X-ray or CT, image quality in MRI depends on
patient compliance. As discussed above, it can be expected
that some sequences may produce unsatisfactory results in
individual patients. Therefore, the use of fast imaging proto-
cols is advocated, with additional sequences to allow for with
a certain degree of redundancy to compensate for any failed
acquisitions [1]. Excellent results will be obtained in young,
compliant subjects with good breath-hold capability. In con-
trast to this, it may become most difficult to obtain diagnostic
image quality in non-compliant, obese patients unable to hold
their breath or unable to understand and follow the breathing
commands. For the latter, parts of the protocol can be acquired
in free breathing, either due to their fast acquisition scheme or
with respiration gated or triggered acquisition modes.
Respiration-triggered versions of the T2-weighted fast spin
echo sequences are available for uncooperative patients who
have difficulties with breath-holding (their application
increases the total in-room time by 10 min). Technicians will
test patient compliance early on in the study, and can adjust the
sequences accordingly. However, it needs to be emphasised
that coaching of patients is very important to gain most
information from any MRI scan. Respiration belts may be
helpful, since this allows for monitoring patient compliance
even during image acquisition [1].
As discussed in the previous article of this series in detail
[MRI of the lung (1/3)], the following protocol suggestions
can be transferred from 1.5- to 3-T MR scanners [17]. While
most sequences, in particular 3D gradient echo techniques,
profit from a higher lesion-to-background contrast to a cer-
tain degree, artefacts may deteriorate the image quality of
steady state gradient echo sequences [17, 21, 77]. Overall,
the changes of image quality with transfer of the concept to
3 T are acceptable or even positive for most sequence types.
Imaging paediatric patients
The lack of radiation exposure makes MRI of the lung
particularly attractive for paediatric radiology. Depending
on experience with the technology and the availability of
scanner time, MRI has become the first-line cross-sectional
imaging technique for pulmonary disease in many depart-
ments [78]. The available sequence techniques are the same
as for adult patients, but characteristic features of the pae-
diatric setting influence the choice of protocols. First of all,
breath-hold imaging is frequently not possible in young
children up to 8 years. Depending on the size of the patients
and their ability to comply with the procedure and breathing
instructions (sometimes even 6-year-old or even younger
children are capable of holding their breath on command),
it appears useful to prepare a separate protocol tree not only
with motion compensated protocols but also with adjusted
fields of view, slice thickness and in-plane resolution with
optimised signal-to-noise ratios for smaller subjects [79].
Two basic strategies have been pursued for motion com-
pensation: fast single shot imaging with very short acquisi-
tion time and respiratory gating/triggering of fast spin echo
techniques. For the first approach, steady state (SSFP) or
partial Fourier single shot sequences (e.g. HASTE) have
been successfully implemented [80]. SSFP sequences allow
for a rapid acquisition of ten slices with breath-hold times
below 10 s, even on low-field MRI systems. Alternatively,
they can be performed during free breathing [81, 82]. Typ-
ically, these fast and robust sequences would be used for an
Fig. 6 A 6-year-old child with
lungmetastases of osteosarcoma.
Both acquisitions, the free
breathing steady state free pre-
cession series (a) and the respi-
ration triggered (navigator
triggered) series (b) show a large
mass with high signal intensity
in the right upper lung lobe in
expiration
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initial overview with further high-resolution acquisitions in
the second part of the examination. The second approach,
gated or triggered acquisition, increases imaging time but
provides better spatial resolution and soft tissue contrast
(Figs. 6, 7) [79, 83]. The higher respiration frequencies of
young children are of a certain advantage since they help
speeding up the acquisition. In most cases, the difference to
non-gated acquisitions is much less than in adult subjects
with low respiration rates. T2-weighted fast spin echo
sequences can be applied with repetition times of 2000 ms
or less, usually triggered to the expiratory phase, which is
around 2 s, depending on the individual respiration frequen-
cy. This time frame allows for excellent T2-weighted images
without relevant motion artefacts [84]. Depending on the
available hardware and specific experience of the team, both
mechanical (respiratory belt or cushion technique [84]) or
image-based (e.g. navigator) devices for the detection of
respiratory motion can be applied with good results. A radial
read-out scheme of the k-space further improves the robustness
against motion artefacts. The application of additional cardiac
triggering may be helpful in specific cases, but paid for with a
significant increase of acquisition time [85].
A second characteristic feature of the paediatric setting is
the need for sedation or general anaesthesia in many cases.
Sedation will normally be avoided as much as possible, but
may be indispensable. In low-field lung MRI it remains a
matter of debate (Rupprecht et al. [82] versus Sanborn et al.
[86]). For propofol sedation, an incidence of up to 42% of
dorsal atelectasis has been described [87]. Other groups use
chloral hydrate or phenobarbital and report less frequent
atelectases (personal communication). However, it is impor-
tant to know this condition, since it may mask relevant
pathology. In case of doubt, additional scans in the prone
position may be warranted. In case exact correlation with
CT is needed, e.g. when switching follow-up examinations
from CT to MRI, it may be useful to acquire the MRI
examination with elevated arms. However, this position is
usually not tolerated by children for more than 15-20 min
and can not be generally recommended.
Protocol suggestions
Based on the published experience and matching the above-
stated expectancies, Table 1 summarises a selection of
Fig. 8 Recent fracture of the left
5th rib as incidental finding in a
29-year-old female volunteer
with left chest pain, hardly visi-
ble on the non-contrast enhanced
T1-weighteg breath-hold 3D
GRE series (a) but with bright
signal on the T2-weighted fat
saturated image from an multiple
breath-hold series (b, arrow)
Fig. 7 Pneumonia (asterisk), chambered pleural effusion (arrowheads)
and abscess (arrow) in the right lower chest of a 6-year-old child, images
acquired in T2-weighted triggered fast spin echo technique
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available sequences and their potential diagnostic yield for
lung MRI. For the overview of concept, details on sequence
technology and parameters are left out here, since dedicated
protocols are described in the literature and may vary in
between different vendors [88–91]. Adjusted to the size of
the patient, the fields of view (FOVs) would be typically
450-500 mm in coronal and approximately 400 mm in trans-
verse acquisitions with matrices of 256-384 pixels (for trig-
gered fast spin echo series up to 512) resulting in pixel sizes
smaller than 1.8 × 1.8 mm. Slice thicknesses for the 2D
acquisitions would range from 4 to 6 mm. Three-dimensional
acquisitions for imaging lung morphology in transverse orien-
tation would use slice thicknesses of 4 mm or less, pulmonary
angiography in coronal orientation 2 mm or less [88]. This is in
line with the QA guidelines for thoracic MRI published by the
German Board of Medicine [92].
A basic or general study combines T1-weighted and T2-
weighted images based on gradient echo and fast spin echo
sequences, respectively [90]. T1-GRE sequences are avail-
able as 3D acquisitions and may, therefore, be limited to a
volume acquisition of the chest in one breath-hold. Fast T2-
weighted spin echo sequences should cover at least two
planes, e.g. with a half Fourier breath-hold acquisition in
coronal and a transverse orientation. This results in a high
sensitivity of the protocol for infiltrates and small nodular
lesions. To improve the sensitivity of the protocol for me-
diastinal lymph nodes and bone lesions (e.g. metastases), a
STIR or fat saturated T2-fast spin echo sequence should be
added. Since rib metastases are easier to detect on transverse
slices, this orientation should be preferred (Fig. 8). The list
of “must” sequences (in the table indicated by G for
“general protocol”) is concluded with a coronal steady-state
free precession sequence in free breathing, which contributes
to a high sensitivity for central pulmonary embolism and gross
cardiac or respiratory dysfunction. As an option (but at the
cost of additional imaging time exceeding the intended limi-
tation to 15 min), motion-compensated T2-weighted fast spin
echo sequences can be added to improve the depiction of
masses with chest-wall invasion [1, 5].
With this selection of non-contrast-enhanced sequences,
the study covers some of the most common potential find-
ings, including pneumonia, atelectasis, pulmonary nodules
or masses, mediastinal masses (lymphoma, goiter, cyst,
thymoma) and acute pulmonary embolism [5]. Depending
on the initial findings following the basic protocol, addition-
al contrast-enhanced acquisitions may be required, which
would use the same type of volume interpolated 3D-GRE
sequence, but now with fat saturation to improve the visi-
bility of contrast-enhanced tissues and mediastinal lymph
nodes (T “tumour protocol”). Although the 3D sequences
cover the whole chest, in-plane resolution is optimised in
either transverse or coronal section (Fig. 9). Since acquisi-
tion times are just one breath-hold, it appears to be feasible
to acquire the 3D GRE studies in at least transverse and
coronal planes. In particular for the staging of lung cancer, it
might be helpful for the detection of small lymph nodes
Fig. 10 An 18-year-old female patient with clinical suspicion
(dyspnoea and elevated D-dimers) of acute pulmonary embolism.
The steady state free precession study shows an embolus inside the
right pulmonary artery (a, arrow) that is also clearly depicted in the
subtraction images form the contrast enhanced 3D flash MRA (b). The
subtraction of the first pass perfusion study (c) confirm large perfusion
deficits in the right lower lobe and a posterior segment of the left upper
lobe (arrowheads)
Fig. 9 A 77-year-old male patient with adenocarcinoma in segment 6
of the right lower lung lobe (arrow; transverse contrast-enhanced
breath-hold 3D GRE study)
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metastases to add a diffusion-weighted sequence as well.
Both sequences extend the total imaging time by approxi-
mately 5 min [1].
The available options for imaging disorders of lung vas-
culature comprise three components: First of all, the free
breathing steady state gradient echo (SSFP-GRE) study
which is also part of the general protocol. Then two varia-
tions of 3D gradient echo based contrast enhanced MRA:
(1) a time-resolved, low spatial resolution acquisition for
first pass perfusion imaging and (2) a high spatial resolution
acquisition for a breath-hold angiogram (Fig. 10). Depend-
ing on the performance of the MR scanner, the dynamic
study produces a comprehensive lung perfusion study with
excellent temporal resolution and at the same time serves for
the determination of optimum contrast bolus timing for the
acquisition of the high resolution angiogram. The “vessel
protocol” (V in Table 1) optimises the sensitivity for acute
and chronic pulmonary embolism, arterio-venous (AV) mal-
formation (e.g. Osler’s disease), lung sequestration, pulmo-
nary arterial aneurysm, abnormalities of pulmonary venous
drainage and any other pathology of lung vasculature [5].
As in other parts of the protocol recommendations, it is
suggested to combine different fast imaging sequences to
increase sensitivity and specificity of the examination [93].
Therefore, Kluge et al. [94] suggested combinations of
different available MRI techniques for the detection of pulmo-
nary embolism [5]. The lung vessel imaging branch of the
protocol tree can be used just for a study of vascular pathology,
e.g. in suspected acute pulmonary embolism or in combination
with the tumour protocol for the comprehensive evaluation of a
central mass with vessel invasion.
These protocol suggestions cover all expected clinical
questions with different branches of the protocol tree for
specific problems. They are a good point to start from and
allow users to make up their own branches based on the
suggested components.
Conclusions
With a comprehensive protocol approach as proposed, MRI
of the lung can be readily performed on most state-of-the-art
1.5-T MRI scanners. Breath-hold imaging or triggered
acquisitions, together with advanced sequence technology
(e.g. parallel imaging and rotating phase encoding), make
image quality reasonably robust against artefacts induced by
respiratory motion and heart action. Parts of the protocol
produce images of diagnostic quality even in uncooperative
patients. This allows for appreciation of the specific features
of lung MRI related to its excellent soft tissue contrast and
functional imaging capacities. The sensitivity of these pro-
tocols for infiltrates is at least similar to X-ray and CT. In
lung nodule detection, MRI is superior to X-ray and almost
as sensitive as CT. A dedicated selection of sequences for
imaging lung vasculature allows for the detection of pulmo-
nary embolism with high sensitivity and specificity. In re-
spect to lung perfusion and respiratory motion, lung MRI
offers additional functional imaging capacities beyond the
scope of X-ray and CT. With this, lung MRI offers not only
solutions for tricky problems of daily routine but also is a
good option for paediatrics and science or any situation
where CT would be (relatively) contra-indicated. A set of
dedicated protocols, as suggested in this article, may help
new users to get started and to stimulate the further devel-
opment of this powerful, third modality for lung imaging
besides X-ray and CT. Further details on how to use the
suggested “toolbox” or “sequence buffet” may be used and
modified for specific clinical applications and how future
perspectives for further protocol developments would look
like will be discussed in the subsequent article of this series.
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